Fluorescence imaging of bladder cancer.
Fluorescence tagging of tumors by sensitizing agents such as hematoporphyrin derivatives is an efficient method for diagnosing tumors but presents, even at low doses, a number of serious drawbacks for the patients. We demonstrate a fiberoptic instrument for the diagnosis of bladder cancer, based on a tripled frequency Nd YAG laser, without need for sensitizing agents, based on the autofluorescence of tissues. The contrast demarcation obtained for CIS and TCC respectively is 2.2 and 2.7, which is about 30% higher than what can be obtained after photosensitizing. The integration of the diagnostic method with a reliable therapeutic technique for tumor cell destruction, opens the way for cost-effective preventive care of high risk patients.
D'Hallewin
M A
MA
Department of Urology, K.U. Leuven, Belgium.
Baert
L
L
Vanherzeele
H
H
D002278:Carcinoma in Situ / Q000175:diagnosis*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis*; D003558:Cystoscopy; D005453:Fluorescence; D006801:Humans; D007834:Lasers; D009354:Neodymium; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis*
D009354:Neodymium